| scholarly article | Q13442814 |
| review article | Q7318358 |
| P2093 | author name string | Niels Olsen Saraiva Câmara | |
| Marina Burgos da Silva | |||
| Cristhiane Favero Aguiar | |||
| Raphael Jose Ferreira Felizardo | |||
| P2860 | cites work | Obesity and Risk for Chronic Renal Failure | Q22241459 |
| Long-term drug treatment for obesity: a systematic and clinical review | Q22253010 | ||
| Adiponectin regulates albuminuria and podocyte function in mice | Q24324384 | ||
| B cells promote insulin resistance through modulation of T cells and production of pathogenic IgG antibodies | Q24598772 | ||
| Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance | Q24617743 | ||
| Eosinophils sustain adipose alternatively activated macrophages associated with glucose homeostasis | Q24629044 | ||
| The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group | Q27861088 | ||
| Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes | Q28188162 | ||
| Diet-induced obesity in C57BL/6J mice causes increased renal lipid accumulation and glomerulosclerosis via a sterol regulatory element-binding protein-1c-dependent pathway | Q28509217 | ||
| Diet-induced insulin resistance in mice lacking adiponectin/ACRP30 | Q28511676 | ||
| Adipose angiotensinogen is involved in adipose tissue growth and blood pressure regulation | Q28588351 | ||
| Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes | Q29547541 | ||
| Obesity induces a phenotypic switch in adipose tissue macrophage polarization | Q29547686 | ||
| Mechanisms linking obesity to insulin resistance and type 2 diabetes | Q29614887 | ||
| Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy | Q29615215 | ||
| Chemical chaperones reduce ER stress and restore glucose homeostasis in a mouse model of type 2 diabetes | Q29615503 | ||
| The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance | Q29616026 | ||
| The hormone resistin links obesity to diabetes | Q29616100 | ||
| Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity | Q29616103 | ||
| CD8+ effector T cells contribute to macrophage recruitment and adipose tissue inflammation in obesity | Q29617380 | ||
| TLR4 links innate immunity and fatty acid-induced insulin resistance | Q29617577 | ||
| The pathobiology of diabetic complications: a unifying mechanism | Q29617766 | ||
| Adipocyte death defines macrophage localization and function in adipose tissue of obese mice and humans | Q29622900 | ||
| PET imaging of leptin biodistribution and metabolism in rodents and primates. | Q30494418 | ||
| Adipose tissue-specific regulation of angiotensinogen in obese humans and mice: impact of nutritional status and adipocyte hypertrophy | Q33742195 | ||
| Pro-inflammatory CD11c+CD206+ adipose tissue macrophages are associated with insulin resistance in human obesity | Q33930230 | ||
| Cardiac remodeling in obesity. | Q34043589 | ||
| Angiotensin II induces nephrin dephosphorylation and podocyte injury: role of caveolin-1 | Q34044253 | ||
| Obesity-related glomerulopathy: an emerging epidemic | Q34190647 | ||
| Obesity and leptin resistance: distinguishing cause from effect | Q34259053 | ||
| Protein kinase C activation and the development of diabetic complications | Q34469779 | ||
| Elevated resistin levels in chronic kidney disease are associated with decreased glomerular filtration rate and inflammation, but not with insulin resistance | Q34482016 | ||
| Association of bodyweight with total mortality and with cardiovascular events in coronary artery disease: a systematic review of cohort studies | Q34558916 | ||
| Differential lipid partitioning between adipocytes and tissue macrophages modulates macrophage lipotoxicity and M2/M1 polarization in obese mice | Q34615417 | ||
| Podocyte is the major culprit accounting for the progression of chronic renal disease | Q34638667 | ||
| Angiotensin II- and salt-induced kidney injury through Rac1-mediated mineralocorticoid receptor activation | Q41896485 | ||
| RAGE drives the development of glomerulosclerosis and implicates podocyte activation in the pathogenesis of diabetic nephropathy | Q42263637 | ||
| Adiponectin is expressed and secreted by renal tubular epithelial cells. | Q42436635 | ||
| Adiponectin gene expression and secretion is inhibited by interleukin-6 in 3T3-L1 adipocytes | Q42805075 | ||
| Visfatin is upregulated in type-2 diabetic rats and targets renal cells | Q43106569 | ||
| Hypoadiponectinemia as a predictor for the development of hypertension: a 5-year prospective study | Q43491850 | ||
| Effect of lipid reduction on the progression of renal disease: a meta-analysis | Q43514434 | ||
| Atherogenic lipoprotein changes in diabetic nephropathy | Q43631871 | ||
| Association between microalbuminuria and the metabolic syndrome: NHANES III | Q43673792 | ||
| Obesity-related hypertension and the role of insulin and leptin in high-fat-fed rabbits | Q44059707 | ||
| Influence of smoking and obesity on the development of proteinuria | Q44091678 | ||
| Angiotensin II regulates the synthesis of proinflammatory cytokines and chemokines in the kidney. | Q44201217 | ||
| The effects of weight loss on renal function in patients with severe obesity | Q44449830 | ||
| Blockade of the renin-angiotensin system increases adiponectin concentrations in patients with essential hypertension | Q44471484 | ||
| Aldosterone antagonism attenuates obesity-induced hypertension and glomerular hyperfiltration. | Q44669038 | ||
| Predictors of new-onset kidney disease in a community-based population | Q44717965 | ||
| Endogenous interleukin-6 enhances the renal injury, dysfunction, and inflammation caused by ischemia/reperfusion | Q45168898 | ||
| Weight loss and the renin-angiotensin-aldosterone system | Q45209925 | ||
| TGF-beta impairs renal autoregulation via generation of ROS. | Q45220024 | ||
| Fat cells may be the obesity-hypertension link: human adipogenic factors stimulate aldosterone secretion from adrenocortical cells | Q45235702 | ||
| Visfatin, a new adipocytokine, is predominantly related to inflammation/endothelial damage in kidney allograft recipients | Q46105885 | ||
| Deletion of the angiotensin type 2 receptor (AT2R) reduces adipose cell size and protects from diet-induced obesity and insulin resistance | Q46406520 | ||
| Angiotensin-II-induced oxidative stress elicits hypoadiponectinaemia in rats | Q46466725 | ||
| Attenuation of diet-induced weight gain and adiposity through increased energy expenditure in mice lacking angiotensin II type 1a receptor | Q46477287 | ||
| Regression of existing glomerulosclerosis by inhibition of aldosterone | Q46726706 | ||
| Body mass index and risk for end-stage renal disease | Q46876497 | ||
| Differential impacts of adiponectin on low-grade albuminuria between obese and nonobese persons without diabetes | Q46965408 | ||
| Angiotensinogen-deficient mice exhibit impairment of diet-induced weight gain with alteration in adipose tissue development and increased locomotor activity | Q47198714 | ||
| Activated macrophages down-regulate podocyte nephrin and podocin expression via stress-activated protein kinases | Q47333969 | ||
| The 10-year incidence of renal insufficiency in people with type 1 diabetes | Q50647488 | ||
| Overexpression of human adiponectin in transgenic mice results in suppression of fat accumulation and prevention of premature death by high-calorie diet. | Q51474615 | ||
| Plasma aldosterone is independently associated with the metabolic syndrome. | Q51496145 | ||
| Free serum leptin but not bound leptin concentrations are elevated in patients with end-stage renal disease. | Q51556048 | ||
| Ambulatory blood pressure and neuroendocrine control after diet-assisted gastric restrictive surgery. | Q51557523 | ||
| Podocyte hypertrophy, "adaptation," and "decompensation" associated with glomerular enlargement and glomerulosclerosis in the aging rat: prevention by calorie restriction. | Q53659984 | ||
| The intrarenal renin-angiotensin system: from physiology to the pathobiology of hypertension and kidney disease. | Q34690091 | ||
| The dysregulated podocyte phenotype: a novel concept in the pathogenesis of collapsing idiopathic focal segmental glomerulosclerosis and HIV-associated nephropathy | Q34756388 | ||
| Rising obesity-related hospital admissions among children and young people in England: national time trends study | Q34775937 | ||
| Normalization of obesity-associated insulin resistance through immunotherapy | Q34994222 | ||
| Podocyte biology and response to injury | Q35005456 | ||
| Benefits of modest weight loss in improving cardiovascular risk factors in overweight and obese individuals with type 2 diabetes | Q35060170 | ||
| Podocyte injury damages other podocytes | Q35108875 | ||
| New insights and perspectives on intrarenal renin-angiotensin system: focus on intracrine/intracellular angiotensin II | Q35109349 | ||
| Hyperfiltration and glomerulosclerosis | Q35110865 | ||
| Moderate dietary sodium restriction added to angiotensin converting enzyme inhibition compared with dual blockade in lowering proteinuria and blood pressure: randomised controlled trial | Q35128415 | ||
| Inflammasome is a central player in the induction of obesity and insulin resistance | Q35216914 | ||
| Kidney function in early diabetes: the tubular hypothesis of glomerular filtration | Q35600696 | ||
| Mediators of diabetic renal disease: the case for tgf-Beta as the major mediator | Q35611125 | ||
| The role of lipids in the development of diabetic microvascular complications: implications for therapy | Q35631434 | ||
| Is obesity a major cause of chronic kidney disease? | Q35632565 | ||
| Valproic acid attenuates proteinuria and kidney injury | Q35758297 | ||
| Obesity and mortality risk among younger dialysis patients | Q35758572 | ||
| New insights into epithelial-mesenchymal transition in kidney fibrosis | Q36010095 | ||
| Aldosterone deficiency and mineralocorticoid receptor antagonism prevent angiotensin II-induced cardiac, renal, and vascular injury. | Q36210088 | ||
| Advanced glycation end products and diabetic nephropathy. | Q36310456 | ||
| Molecular mechanisms and therapeutic strategies of chronic renal injury: renoprotective effects of aldosterone blockade | Q36362313 | ||
| Obesity and diabetic kidney disease | Q36515043 | ||
| Adiponectin promotes functional recovery after podocyte ablation | Q36574746 | ||
| Leptin and renal fibrosis | Q36575277 | ||
| Serum adiponectin levels and mortality after kidney transplantation | Q36652777 | ||
| Genetic deficiency of adiponectin protects against acute kidney injury | Q36728842 | ||
| Adipokines mediate inflammation and insulin resistance | Q36920864 | ||
| Adverse renal consequences of obesity | Q37072213 | ||
| The pathogenesis of diabetic nephropathy | Q37209550 | ||
| Metabolic syndrome, vitamin D deficiency and hypoadiponectinemia among nondiabetic patients early after kidney transplantation | Q37277578 | ||
| Leptin acts in the forebrain to differentially influence baroreflex control of lumbar, renal, and splanchnic sympathetic nerve activity and heart rate | Q37296664 | ||
| Obesity-associated liver disease | Q37318500 | ||
| The brain subfornical organ mediates leptin-induced increases in renal sympathetic activity but not its metabolic effects | Q37322253 | ||
| JNK expression by macrophages promotes obesity-induced insulin resistance and inflammation | Q37330051 | ||
| Structure-stabilizing forces in the glomerular tuft. | Q55065103 | ||
| Loss-of-function mutation in Toll-like receptor 4 prevents diet-induced obesity and insulin resistance | Q56742768 | ||
| Olmesartan for the Delay or Prevention of Microalbuminuria in Type 2 Diabetes | Q57605349 | ||
| Bradykinin receptor 1 activation exacerbates experimental focal and segmental glomerulosclerosis | Q58007003 | ||
| Effect of interleukin-6 receptor blockage on renal injury in apolipoprotein E-deficient mice | Q58363469 | ||
| Effect of Obesity on the Outcome of Kidney Transplantation: A 20-Year Follow-Up | Q59591389 | ||
| Increasing Body Mass Index and Obesity in the Incident ESRD Population | Q60777261 | ||
| Prevalence of Renal Insufficiency in Individuals with Hypertension and Obesity/Overweight: The FATH Study | Q61455844 | ||
| Serum visfatin concentration and endothelial dysfunction in chronic kidney disease | Q61927943 | ||
| Exacerbation of albuminuria and renal fibrosis in subtotal renal ablation model of adiponectin-knockout mice | Q64377067 | ||
| Glomerular damage after uninephrectomy in young rats. II. Mechanical stress on podocytes as a pathway to sclerosis | Q68216638 | ||
| The Diabetes Control and Complications Trial (DCCT). Design and methodologic considerations for the feasibility phase. The DCCT Research Group | Q69878862 | ||
| Glomerular sclerosis in patients with massive obesity | Q70055629 | ||
| The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group | Q70513402 | ||
| Plasma lipids and the progression of nephropathy in diabetes mellitus type II: effect of ACE inhibitors | Q72242502 | ||
| A new single nephron model of focal and segmental glomerulosclerosis in the Munich-Wistar rat | Q72290102 | ||
| Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study | Q72779135 | ||
| Glomerular hemodynamics in severe obesity | Q73782711 | ||
| Functional and structural changes in the kidney in the early stages of obesity | Q73928010 | ||
| Angiotensin II type 1-receptor mediated changes in heparan sulfate proteoglycans in human SV40 transformed podocytes | Q75205967 | ||
| The impact of body mass index on renal transplant outcomes: a significant independent risk factor for graft failure and patient death | Q77493952 | ||
| Demographics and trends in overweight and obesity in patients at time of kidney transplantation | Q78847092 | ||
| Adiponectin and mortality in patients with chronic kidney disease | Q80050959 | ||
| Renal functional reserve in obesity hypertension | Q80281324 | ||
| Meta-analysis: effect of monotherapy and combination therapy with inhibitors of the renin angiotensin system on proteinuria in renal disease | Q81555894 | ||
| Obesity-induced glomerular hyperfiltration: its involvement in the pathogenesis of tubular sodium reabsorption | Q81630363 | ||
| Effect of bariatric surgery on normal and abnormal renal function | Q83312976 | ||
| Overweight and obesity accelerate the progression of IgA nephropathy: prognostic utility of a combination of BMI and histopathological parameters | Q83476714 | ||
| Influence of obesity on progression of non-diabetic chronic kidney disease: a retrospective cohort study | Q84203178 | ||
| Visfatin is related to lipid dysregulation, endothelial dysfunction and atherosclerosis in patients with chronic kidney disease | Q84523925 | ||
| Plasma adiponectin before and after kidney transplantation | Q85003224 | ||
| Physiology of obesity and effects on lung function | Q37624329 | ||
| Weight loss and proteinuria: systematic review of clinical trials and comparative cohorts. | Q37640916 | ||
| Role of triglyceride-rich lipoproteins in diabetic nephropathy | Q37741779 | ||
| The effect of obesity on chronic kidney disease | Q37825085 | ||
| Hypertension in diabetic nephropathy: epidemiology, mechanisms, and management | Q37827620 | ||
| Bariatric surgery and renal function | Q37843766 | ||
| Management of blood pressure in patients with diabetes | Q37869806 | ||
| Angiotensin II as a morphogenic cytokine stimulating renal fibrogenesis | Q37896399 | ||
| The impact of extended care on the long-term maintenance of weight loss: a systematic review and meta-analysis. | Q37972791 | ||
| Adipose tissue-resident immune cells: key players in immunometabolism. | Q38026316 | ||
| Improving the efficacy of RAAS blockade in patients with chronic kidney disease | Q38068099 | ||
| Hypoxia and adipose tissue function and dysfunction in obesity. | Q38072900 | ||
| Structural renal changes in obesity and diabetes | Q38078544 | ||
| Direct and indirect effects of obesity on the kidney | Q38084514 | ||
| Renal epithelial injury and fibrosis | Q38087160 | ||
| Adipose tissue hypoxia in obesity and its impact on adipocytokine dysregulation | Q38303256 | ||
| Pre- and postprandial expression of the leptin receptor splice variants OB-Ra and OB-Rb in murine peripheral tissues | Q38319448 | ||
| Leptin stimulates proliferation and TGF-beta expression in renal glomerular endothelial cells: potential role in glomerulosclerosis [seecomments] | Q38321070 | ||
| Plasma leptin is partly cleared by the kidney and is elevated in hemodialysis patients | Q38345536 | ||
| Body mass index is associated with hospital mortality in critically ill patients: an observational cohort study | Q38426273 | ||
| Long-term effects of weight loss and dietary sodium reduction on incidence of hypertension | Q39061314 | ||
| Adipocytes produce aldosterone through calcineurin-dependent signaling pathways: implications in diabetes mellitus-associated obesity and vascular dysfunction | Q39366285 | ||
| Protective effects of adiponectin against renal ischemia-reperfusion injury via prostacyclin-PPARα-heme oxygenase-1 signaling pathway | Q39574974 | ||
| High glucose-induced transforming growth factor beta1 production is mediated by the hexosamine pathway in porcine glomerular mesangial cells | Q39796701 | ||
| Obesity-related hypertension: epidemiology, pathophysiology, and clinical management | Q39848035 | ||
| The effect of a shift in sodium intake on renal hemodynamics is determined by body mass index in healthy young men. | Q40271917 | ||
| Link between angiotensin II and TGF-beta in the kidney. | Q41731306 | ||
| P433 | issue | 3 | |
| P921 | main subject | obesity | Q12174 |
| kidney disease | Q1054718 | ||
| P304 | page(s) | 50-63 | |
| P577 | publication date | 2014-08-01 | |
| P1433 | published in | World journal of nephrology | Q27724911 |
| P1476 | title | Obesity in kidney disease: A heavyweight opponent | |
| P478 | volume | 3 |
| Q27322539 | Anti-Inflammatory Effects of Ang-(1-7) in Ameliorating HFD-Induced Renal Injury through LDLr-SREBP2-SCAP Pathway |
| Q36958908 | Leptin deficiency down-regulates IL-23 production in glomerular podocytes resulting in an attenuated immune response in nephrotoxic serum nephritis |
| Q92702386 | Lipid Accumulation and Chronic Kidney Disease |
| Q39085575 | Matrix Metalloproteinase Neutrophil Gelatinase-Associated Lipocalin Complex Predicts Atrial Fibrillation Recurrence after Electrical Cardioversion in Obese Patients |
| Q48698019 | Obesity-related glomerulopathy: pathogenesis, pathologic, clinical characteristics and treatment |
| Q36328309 | Precocious obesity predisposes the development of more severe cisplatin-induced acute kidney injury in young adult mice |
| Q51118569 | Protective Effects of Glucagon-Like Peptide-1 Analog on Renal Tubular Injury in Mice on High-Fat Diet |
| Q92824810 | Reduction in Urinary Chemokine (C-C Motif) Ligand 2 (CCL2) After Surgery-Induced Weight Loss |
| Q38429861 | The kidney in obesity |
| Q41202467 | Urinary fibrogenic cytokines ET-1 and TGF-β1 are associated with urinary angiotensinogen levels in obese children |
Search more.